Published in Cancer Res on July 01, 1997
A perspective of polyamine metabolism. Biochem J (2003) 3.24
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci U S A (2003) 1.56
Hairless and the polyamine putrescine form a negative regulatory loop in the epidermis. Exp Dermatol (2013) 1.39
Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma. Cancer Res (2009) 1.09
Molecular mechanisms of mouse skin tumor promotion. Cancers (Basel) (2010) 1.09
Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice. J Clin Invest (2004) 1.03
Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer. Mol Cancer Res (2011) 1.00
Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression. Biochem J (2000) 0.98
Characterization of transgenic mice with widespread overexpression of spermine synthase. Biochem J (2004) 0.97
Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors. Cancer Res (2010) 0.97
A definitive role of ornithine decarboxylase in photocarcinogenesis. Am J Pathol (2001) 0.93
A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development. Carcinogenesis (2011) 0.93
Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol (2006) 0.92
Critical factors determining dimerization of human antizyme inhibitor. J Biol Chem (2009) 0.90
Effect of spermine synthase on the sensitivity of cells to anti-tumour agents. Biochem J (2003) 0.90
Deregulation of common genes by c-Myc and its direct target, MT-MC1. Proc Natl Acad Sci U S A (2005) 0.89
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma. Front Oncol (2012) 0.89
Increased polyamine intake inhibits age-associated alteration in global DNA methylation and 1,2-dimethylhydrazine-induced tumorigenesis. PLoS One (2013) 0.89
Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment. Cancer Immunol Res (2013) 0.88
Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor. J Med Chem (2009) 0.88
The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice. J Invest Dermatol (2000) 0.87
Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers. Int J Pharm (2007) 0.87
Elevated epidermal ornithine decarboxylase activity suppresses contact hypersensitivity. J Invest Dermatol (2010) 0.85
Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines. Cancer Growth Metastasis (2015) 0.84
c-Jun activation-dependent tumorigenic transformation induced paradoxically by overexpression or block of S-adenosylmethionine decarboxylase. J Cell Biol (2000) 0.83
Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model. J Biol Chem (2010) 0.83
Critical factors governing the difference in antizyme-binding affinities between human ornithine decarboxylase and antizyme inhibitor. PLoS One (2011) 0.82
Posttranscriptional regulation of ornithine decarboxylase. Methods Mol Biol (2011) 0.82
Determinants of the differential antizyme-binding affinity of ornithine decarboxylase. PLoS One (2011) 0.81
P elements inserted in the vicinity of or within the Drosophila snRNP SmD3 gene nested in the first intron of the Ornithine Decarboxylase Antizyme gene affect only the expression of SmD3. Genetics (2002) 0.81
Keratin-6 driven ODC expression to hair follicle keratinocytes enhances stemness and tumorigenesis by negatively regulating Notch. Biochem Biophys Res Commun (2014) 0.81
Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes. Cancer Res (2008) 0.80
Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions. World J Gastroenterol (2007) 0.80
Combination of physical activity, nutrition, or other metabolic factors and vaccine response. Front Biosci (2007) 0.80
Polyamines regulate gap junction communication in connexin 43-expressing cells. Biochem J (2001) 0.80
Germline Mutations in Mtap Cooperate with Myc to Accelerate Tumorigenesis in Mice. PLoS One (2013) 0.79
Hydroxydibenzoylmethane induces apoptosis through repressing ornithine decarboxylase in human promyelocytic leukemia HL-60 cells. Exp Mol Med (2011) 0.79
Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol. Cancer Prev Res (Phila) (2009) 0.78
Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis. J Mol Model (2009) 0.78
Characterization of transgenic mice with overexpression of spermidine synthase. Amino Acids (2011) 0.77
Phosphorylated human keratinocyte ornithine decarboxylase is preferentially associated with insoluble cellular proteins. Mol Biol Cell (1999) 0.77
Growth-inhibitory effects of the chemopreventive agent indole-3-carbinol are increased in combination with the polyamine putrescine in the SW480 colon tumour cell line. BMC Cancer (2003) 0.77
Food polyamine and cardiovascular disease--an epidemiological study. Glob J Health Sci (2012) 0.77
S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion. Carcinogenesis (2012) 0.76
Functional roles of the dimer-interface residues in human ornithine decarboxylase. PLoS One (2014) 0.76
Therapy of murine squamous cell carcinomas with 2-difluoromethylornithine. J Carcinog (2004) 0.76
Structural basis of Ornithine Decarboxylase inactivation and accelerated degradation by polyamine sensor Antizyme1. Sci Rep (2015) 0.75
One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling. Int J Mol Sci (2016) 0.75
Gene polymorphisms in the ornithine decarboxylase-polyamine pathway modify gastric cancer risk by interaction with isoflavone concentrations. Gastric Cancer (2014) 0.75
Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J Cell Biol (1995) 3.86
P- and E-cadherin are in separate complexes in cells expressing both cadherins. Exp Cell Res (1993) 1.72
Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J Membr Biol (1998) 1.30
Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets. J Cell Sci (2000) 1.28
Wnt-1 dependent activation of the survival factor NF-kappaB in PC12 cells. J Neurosci Res (2000) 1.27
Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability. Am J Physiol (1992) 1.12
Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia (2001) 1.10
Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res (1995) 1.06
Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch Pathol Lab Med (2000) 1.00
K6/ODC transgenic mice as a sensitive model for carcinogen identification. Toxicol Lett (2000) 0.98
Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res (1995) 0.95
Polyamines regulate expression of the neoplastic phenotype in mouse skin. Cancer Res (1998) 0.95
Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas. Carcinogenesis (1991) 0.94
Overexpression of protein kinase C-delta increases tight junction permeability in LLC-PK1 epithelia. Am J Physiol (1998) 0.89
Transepithelial paracellular leakiness induced by chronic phorbol ester exposure correlates with polyp-like foci and redistribution of protein kinase C-alpha. Carcinogenesis (1997) 0.88
Ornithine decarboxylase expression leads to translocation and activation of protein kinase CK2 in vivo. J Biol Chem (1997) 0.88
Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Hum Pathol (1999) 0.86
Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity. J Invest Dermatol (1996) 0.86
Cell division does not increase transepithelial permeability of LLC-PK1 cell sheets. Exp Cell Res (1995) 0.85
Chronic exposure of LLC-PK1 epithelia to the phorbol ester TPA produces polyp-like foci with leaky tight junctions and altered protein kinase C-alpha expression and localization. Exp Cell Res (1996) 0.84
Overexpression of neural cell adhesion molecule in Chagas' myocarditis. Hum Pathol (2001) 0.83
N-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas: a ThinPrep immunocytochemical study. Cancer (1999) 0.82
Cadherin-mediated cell-cell interactions. Methods Mol Biol (2000) 0.79
Intranuclear localization of insulin in rat hepatoma cells: insulin/matrix association. Eur J Cell Biol (1989) 0.79
Abnormal ornithine decarboxylase activity in transgenic mice increases tumor formation and infertility. Int J Biochem Cell Biol (2001) 0.78
Cypermethrin-induced apoptosis in the telencephalon of Physalaemus biligonigerus tadpoles (Anura: Leptodactylidae). Bull Environ Contam Toxicol (2000) 0.78
Regulation of protein kinase C-delta and -epsilon isoforms by phorbol ester treatment of LLC-PK1 renal epithelia. Kidney Int (2000) 0.77
Lack of correlation between serum levels of E- and P-cadherin fragments and the presence of breast cancer. Hum Pathol (2000) 0.76
Alterations induced by E-cadherin and beta-catenin antibodies during the development of Bufo arenarum (Anura-Bufonidae). Histol Histopathol (2001) 0.75
Expression of N-CAM-180 and N-cadherin during development in two South-American anuran species (Bufo arenarum and Hyla nana). Eur J Histochem (2000) 0.75